Effect of indomethacin and deendothelisation on vascular responses in the renal artery

Physiological Research

Volumn 49, Issue 1, 2000, Pages 129-133

  Kristova V ^a   Kriska M ^a   Vojtko, R ^a   Kurtansky A ^a  

^a Bratislava   (Slovakia)

Author keywords

Deendothelisation; Indomethacin; Renal artery; Vasoconstrictor responses

Indexed keywords

INDOMETACIN; NITRIC OXIDE; NORADRENALIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; DRUG EFFECT; FEMALE; KIDNEY BLOOD FLOW; MALE; NONHUMAN; RABBIT; RENAL ARTERY; VASCULAR RESISTANCE; VASOCONSTRICTION;

ANIMALS; CYCLOOXYGENASE INHIBITORS; ENDOTHELIUM, VASCULAR; FEMALE; INDOMETHACIN; MALE; NOREPINEPHRINE; RABBITS; RENAL ARTERY; VASOCONSTRICTION;

EID: 0033956108     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. BATTISTINI B, BOTTING R, BAKHLE YS: COX-1 and COX-2: toward the development of more selective NSAIDs. Drug News Perspect 7: 501-512, 1994.
2. CARMICHAEL J, SHANKEL SW: Effects of NSAIDs on prostaglandins and renal functions. Am J Med 78: 992-1000, 1985.
3. CARRIER GO, WHITE RE: Enhancement of alpha-1 and alpha-2 adrenergic agonists induced vasoconstriction by removal of endothelium in rat aorta. J Pharmacol Exp Ther 232: 682-687, 1985.
4. DI ROSA M, IALENTI A, IANARO A, SAUTEBIN L: Interactions between nitric oxide and cyclooxygenase pathways. Prostagland Leukot Essent Fatty Acids 54: 229-238, 1996.
5. DJIBRIL MN, KRISTOVÁ V, FAČKOVCOVÁ D, KRIŠKA M: Comparison of vascular responses to selected NSAIDs in rabbit femoral and renal arteries. Acta Physiol Hung (in press).
6. GARDINER SM, COMPTON AM, BENNETT T, PALMER RMJ, MONCADA S: Control of regional blood flow by endothelium-derived nitric oxide. Hypertension 15: 486-492, 1990.
7. GONZÁLES JD, LLINÁS MT, NAVA E, GHIADONI L, SALAZAR FJ: Role of nitric oxide and prostaglandins in the long-term control of renal function. Hypertension 32: 33-38, 1998.
8. GUDE NM, KING RG, BRENNECKE SP: Autacoid interactions in the regulation of blood flow in the human placenta. Clin Exp Pharmacol Physiol 25: 706-711, 1998.
9. KRIŠKA M, BABÁL P, KRISTOVÁ V, CAŇOVÁ R: The evaluation of perfused vessel reactivity in relation to the endothelium (in Slovak). Čs Fysiol 38: 153, 1989.
10. KRIŠKA M, KRISTOVÁ V, VOJTKO R, KURTANSKÝ A: Effect of indomethacin and deendothelisation on vascular responses in the renal artery. Physiol Res 48: 33P, 1999.
11. KRISTOVÁ V, DJIBRIL MN, VOJTKO R, KRIŠKA M, KURTANSKÝ A: Effect of L-NNA and indomethacin interactions on noradrenaline-induced vasoconstrictions in renal and femoral arteries. Pflügers Arch 437 (Suppl): R161 1999.
12. MALOMVOLGYI B, HADHAZY P, TEKES K, KOLTAI MZ, POGATSA G: Comparison of the vasodilatory effects of bradykinin in isolated dog renal arteries and in buffer-perfused dog kidneys. Acta Physiol Hung 84: 9-18, 1996.
13. MCLAUGHLIN JK, LIPWORTH L, CHOW WH, BLOT WJ: Analgesic use and chronic renal failure: a critical review of the epidemiologic literature. Kidney Int 54: 679-686, 1998.
14. MICHIBAYASHI T: Effect of endogenous prostaglandin E on the vasoconstrictor response to noradrenaline. Jpn J Pharmacol 36: 365-370, 1984.
15. PALMER BIFF F: Renal complications associated with use of NSAIDs. Invest Med 43: 516-533, 1995.
16. PAIRET M, ENGELHARDT G: Differential inhibition of COX-1 and COX-2 in vitro and pharmacological profile in vivo of NSAIDs. In: Improved Non-steroid Anti-inflammatory Drugs. COX-2 Enzyme Inhibitors. J VANE, J BOTTING, R BOTTING (eds), Kluwer Academic Publishers, Dortmund, William Harvey Press, New York, 1996, pp 103-119.
17. REES D, PALMER RMJ, MONCADA S: Role of endothelium-derived nitric oxide in regulation of blood pressure. Proc Natl Acad Sci USA 86: 3375-3378, 1989.
18. TESFAMARIAM B, WEISBROD RM, COHEN RA: Cyclic GMP modulators of vascular adrenergic neurotransmission. J Vasc Res 29: 396-404, 1992.
19. VANE JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231: 232-235, 1971.